Abeona Therapeutics (ABEO) Total Debt (2010 - 2026)

Abeona Therapeutics' Total Debt history runs 14 years deep, the most recent figure standing at $18.1 million for Q1 2026.

• In Q1 2026, Total Debt fell 6.22% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $18.1 million (down 6.22% YoY), while the FY2025 annual figure was $20.0 million, up 5.65% from the prior year.
• Total Debt for Q1 2026 stood at $18.1 million, down from $20.0 million in the prior quarter.
• The five-year high for Total Debt was $22.8 million in Q1 2024, with the low at $4.2 million in Q4 2022.
• The 5-year median for Total Debt is $18.5 million (2024), against an average of $15.0 million.
• Peak annual rise in Total Debt reached 402.22% in 2022, while the deepest fall reached 74.73% in 2022.
• Abeona Therapeutics' Total Debt stood at $4.2 million in 2022, then increased by 10.02% to $4.6 million in 2023, then jumped by 314.04% to $19.0 million in 2024, then rose by 5.65% to $20.0 million in 2025, then dropped by 9.72% to $18.1 million in 2026.
• Business Quant data shows ABEO's Total Debt at $18.1 million in Q1 2026, $20.0 million in Q4 2025, and $19.8 million in Q3 2025.